1-3 of 3
Xin Du
Close
Save search
Sort by
Journal Articles

Long-term Efficacy and Safety of Ropeginterferon Alfa-2b under its HIDAT Regimen for the Treatment of Polycythemia Vera

Open Access
Shanshan Suo, Rongfeng Feng Fu, Albert Qin, Dr., Zonghong Shao, Jie Bai, Hu Zhou, Na Xu, Suning Chen, Xuelan Zuo, Xin Du, Minghui Duan, Li Wang, Pei Li, Xuhan Zhang, Sujiang Zhang, Daoxiang Wu, Jingjing Zhang, Zhijian Xiao, Lei Zhang, Jie Jin
Journal: Blood Advances
Blood Adv bloodadvances.2025017938.
https://doi.org/10.1182/bloodadvances.2025017938
Published: 2025
Includes: Supplemental data
Journal Articles

A global study for acute myeloid leukemia with RARG rearrangement

Free
Hong-Hu Zhu, Ya-Zhen Qin, Zhang-Lin Zhang, Yong-Jing Liu, Li-Jun Wen, M. James You, Cheng Zhang, Esperanza Such, Hong Luo, Hong-Jian Yuan, Hong-Sheng Zhou, Hong-Xing Liu, Reng Xu, Ji Li, Jian-Hu Li, Jian-Ping Hao, Jie Jin, Liang Yu, Jing-Ying Zhang, Li-Ping Liu, Le-Ping Zhang, Rui-Bin Huang, Shu-Hong Shen, Su-Jun Gao, Wei Wang, Xiao-Jing Yan, Xin-You Zhang, Xin Du, Xiao-Xia Chu, Yan-Fang Yu, Yi Wang, Ying-Chang Mi, Ying Lu, Zhen Cai, Zhan Su, David Christopher Taussig, Suzanne MacMahon, Edward D. Ball, Huan-You Wang, John S. Welch, C. Cameron Yin, Gautam Borthakur, Miguel A. Sanz, Hagop M. Kantarjian, Jin-Yan Huang, Jiong Hu, Su-Ning Chen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2972–2982.
https://doi.org/10.1182/bloodadvances.2022008364
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of response kinetics for multiple myeloma in the era of novel agents

Free
Clinical Trials & Observations
Yuting Yan, Xuehan Mao, Jiahui Liu, Huishou Fan, Chenxing Du, Zengjun Li, Shuhua Yi, Yan Xu, Rui Lv, Wei Liu, Shuhui Deng, Weiwei Sui, Qi Wang, Dehui Zou, Jianxiang Wang, Tao Cheng, Fenghuang Zhan, Yu-Tzu Tai, Chenglu Yuan, Xin Du, Lugui Qiu, Kenneth C. Anderson, Gang An
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2895–2904.
https://doi.org/10.1182/bloodadvances.2019000432
Published: 2019
Includes: Supplemental data